关注
Yu-Cheng Tseng
Yu-Cheng Tseng
University of North Carolina at Chapel Hill
在 nrtpharma.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lipid-based systemic delivery of siRNA
YC Tseng, S Mozumdar, L Huang
Advanced drug delivery reviews 61 (9), 721-731, 2009
5762009
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
J Li, YC Chen, YC Tseng, S Mozumdar, L Huang
Journal of controlled release 142 (3), 416-421, 2010
5302010
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
Z Xu, S Ramishetti, YC Tseng, S Guo, Y Wang, L Huang
Journal of Controlled Release 172 (1), 259-265, 2013
2332013
Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer
WH Chen, RLG Lecaros, YC Tseng, L Huang, YC Hsu
Cancer letters 359 (1), 65-74, 2015
1352015
Lipid–calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases
YC Tseng, Z Xu, K Guley, H Yuan, L Huang
Biomaterials 35 (16), 4688-4698, 2014
1172014
Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?
Y Liu, Y Tseng, L Huang
Pharmaceutical research 29, 3273-3277, 2012
1092012
How does the cell overcome LCP nanoparticle-induced calcium toxicity?
YC Tseng, A Yang, L Huang
Molecular pharmaceutics 10 (11), 4391-4395, 2013
442013
Self-assembled lipid nanomedicines for siRNA tumor targeting
YC Tseng, L Huang
Journal of biomedical nanotechnology 5 (4), 351-363, 2009
352009
LCP nanoparticle for tumor and lymph node metastasis imaging
YC Tseng
The University of North Carolina at Chapel Hill, 2013
12013
Abstract B10: Overcoming resistance to B-Raf targeting agents using LPD nanotechnology
CY Chung, Y Wang, WY Sheng, YC Tseng, T Dick, L Huang, G Robertson
Clinical Cancer Research 18 (10_Supplement), B10-B10, 2012
2012
系统目前无法执行此操作,请稍后再试。
文章 1–10